TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive In Brief: San Antonia Cancer Institute Designated Comprehensive; Yeast DNA Described May 3, 1996
TCL Archive NCAB Committee Agrees On Seven Characteristics For Comprehensive Centers, Asks For New Division May 12, 1989
TCL Archive FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say January 26, 1996
